BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24603447)

  • 1. EuroSCORE II with SYNTAX score to assess risks of coronary artery bypass grafting outcomes.
    Fukui T; Uchimuro T; Takanashi S
    Eur J Cardiothorac Surg; 2015 Jan; 47(1):66-71. PubMed ID: 24603447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.
    Shen L; Hu S; Wang H; Xiong H; Zheng Z; Li L; Xu B; Yan H; Gao R
    J Am Coll Cardiol; 2013 Jun; 61(25):2525-33. PubMed ID: 23623906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
    Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
    JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE.
    Leacche M; Byrne JG; Solenkova NS; Reagan B; Mohamed TI; Fredi JL; Zhao DX
    J Thorac Cardiovasc Surg; 2013 Apr; 145(4):1004-1012. PubMed ID: 22541514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SYNTAX score is correlated with long-term outcomes of coronary artery bypass grafting for complex coronary artery lesions.
    Cho Y; Shimura S; Aki A; Furuya H; Okada K; Ueda T
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):125-32. PubMed ID: 26984964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
    Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
    JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexity of coronary artery disease affects outcome of patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Melina G; Angeloni E; Benedetto U; Monti F; Roscitano A; Serdoz R; Sinatra R
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):656-61. PubMed ID: 22995728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SYNTAX Score is associated with worse outcomes after off-pump coronary artery bypass grafting surgery for three-vessel or left main complex coronary disease.
    Carnero-Alcázar M; Maroto Castellanos LC; Silva Guisasola JA; Cobiella Carnicer J; Alswies A; Fuentes Ferrer ME; Rodríguez Hernández JE
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):e123-32. PubMed ID: 21269648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
    Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.
    Capodanno D; Capranzano P; Di Salvo ME; Caggegi A; Tomasello D; Cincotta G; Miano M; Patané M; Tamburino C; Tolaro S; Patané L; Calafiore AM; Tamburino C
    JACC Cardiovasc Interv; 2009 Aug; 2(8):731-8. PubMed ID: 19695541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years.
    Mohr FW; Rastan AJ; Serruys PW; Kappetein AP; Holmes DR; Pomar JL; Westaby S; Leadley K; Dawkins KD; Mack MJ
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):130-40. PubMed ID: 21168023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
    JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
    Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexity of coronary vasculature predicts outcome of surgery for left main disease.
    Birim O; van Gameren M; Bogers AJ; Serruys PW; Mohr FW; Kappetein AP
    Ann Thorac Surg; 2009 Apr; 87(4):1097-104; discussion 1104-5. PubMed ID: 19324134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.
    Chakravarty T; Buch MH; Naik H; White AJ; Doctor N; Schapira J; Mirocha JM; Fontana G; Forrester JS; Makkar R
    Am J Cardiol; 2011 Feb; 107(3):360-6. PubMed ID: 21256999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of EuroSCORE II in patients undergoing coronary artery bypass surgery.
    Biancari F; Vasques F; Mikkola R; Martin M; Lahtinen J; Heikkinen J
    Ann Thorac Surg; 2012 Jun; 93(6):1930-5. PubMed ID: 22516834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does CHA
    Kalyoncuoglu M; Ozturk S; Sahin M
    Braz J Cardiovasc Surg; 2019 Dec; 34(5):542-549. PubMed ID: 31112030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.